Ascentage Pharma Group International (HKSE:06855) Change In Inventory : HK$0 Mil (TTM As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Ascentage Pharma Group International Change In Inventory?

Ascentage Pharma Group International's change in inventory for the quarter that ended in Dec. 2024 was HK$0 Mil. It means Ascentage Pharma Group International's inventory stayed the same from Jun. 2024 to Dec. 2024 .

Ascentage Pharma Group International's change in inventory for the fiscal year that ended in Dec. 2024 was HK$10 Mil. It means Ascentage Pharma Group International's inventory declined by HK$10 Mil from Dec. 2023 to Dec. 2024 .

Ascentage Pharma Group International's Total Inventories for the quarter that ended in Dec. 2024 was HK$7 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Ascentage Pharma Group International's Days Inventory for the quarter that ended in Dec. 2024 was 113.22.

Inventory Turnover measures how fast the company turns over its inventory within a year. Ascentage Pharma Group International's Inventory Turnover for the quarter that ended in Dec. 2024 was 1.61.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Ascentage Pharma Group International's Inventory-to-Revenue for the quarter that ended in Dec. 2024 was 0.06.

Ascentage Pharma Group International Change In Inventory Historical Data

The historical data trend for Ascentage Pharma Group International's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascentage Pharma Group International Change In Inventory Chart

Ascentage Pharma Group International Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Inventory

Get a 7-Day Free Trial

-4.81

-6.16

-7.35

10.22

Ascentage Pharma Group International Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Change In Inventory	Get a 7-Day Free Trial											-	-	-	-	-

Ascentage Pharma Group International Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0 Mil.

Ascentage Pharma Group International (HKSE:06855) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Ascentage Pharma Group International's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	9.2905	/	14.975	*	365 / 2
	=	113.22

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Ascentage Pharma Group International's Inventory Turnover for the quarter that ended in Dec. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	14.975	/	9.2905
	=	1.61

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Ascentage Pharma Group International's Inventory to Revenue for the quarter that ended in Dec. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	9.2905	/	167.522
	=	0.06

Ascentage Pharma Group International Change In Inventory Related Terms

Thank you for viewing the detailed overview of Ascentage Pharma Group International's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Ascentage Pharma Group International Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascentage Pharma Group International (HKSE:06855) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

AAPG:USA 36X:Germany

Address

68 Xinqing Road, Suzhou Industrial Park, Jiangsu, Suzhou, CHN, 215000

Website

https://www.ascentagepharma.com

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.

Executives

Jpmorgan Chase & Co.	2201 Interest of corporation controlled by you
Takeda Pharmaceuticals International Ag	2101 Beneficial owner
Takeda Pharmaceuticals Company Limited	2201 Interest of corporation controlled by you
Gao Sharon Xia
Zhai Yifan
Yang Dajun
Wang Shaomeng
Li Ju-yun
Healthquest Pharma Limited
Guo Edward Ming
Ascentage Limited
South Dakota Trust Company Llc	2301 Trustee
Tian Yuan	2201 Interest of corporation controlled by you
Zhao Li	2202 Interest of your spouse
Xian Jin Zhi Zao Chan Ye Tou Zi Ji Jin You Xian He Huo	2201 Interest of corporation controlled by you

Ascentage Pharma Group International Headlines

No Headlines